Blog Contact Us EN DE We enable our partners to succeed by doing what we do best Since 1984 we have been focused on utilizing our expertise, experience and innovation to create market leading drug delivery solutions for our pharmaceutical partners. Our three-point purpose READ MORE Our three-point outcomes CREATING new therapeutic opportunities MAXIMISING partner value IMPROVING patient outcomes LTS in numbers 1.100 employees 800 Mio. systems produced 300 patent families owned Our major milestones 2019 The manufacturer’s authorisation for LTS is extended to the manufacturing of capsules. 2014 LTS manufactures the first OTF for the treatment of breakthrough pain in chronic cancer pain. 2013 Launch of an ondansetrone OTF for the treatment and prophylaxis of acute nausea and vomiting induced by moderately emetogenic chemotherapy. 2012 Launch of the first ibuprofen patch, a local analgesic for the treatment of articular painful conditions, both traumatic and rheumatic. 2007 Launch of the first transdermal patch for the treatment of Alzheimer’s disease 2006 Launch of the first transdermal patch for the treatment of Parkinson’s disease 1990 The first nicotine patch for smoking cessation is launched in the US 1984 The first TTS matrix system from LTS achieves approval and is launched, a nitroglycerin patch. There are no barriers to working with us, only opportunities. Contact us Name E-Mail * Company Select your location * EU USA ASIA OTHER Message *Required Field | Please read our Privacy Policy SUBMIT With teams of experts on hand across the globe, we are here to support your next innovative drug delivery development programme. EUROPE +49 2632 990 THE AMERICAS +1 973 575 5170 FAR EAST +86 21 5081 2266 ext. 1832 IMPRINT PRIVACY STATEMENT PHOTO-CREDITS SITEMAP © 2016-2021 LTS Lohmann Therapie-Systeme AG Cookie Settings Privacy settings We use cookies on our website. Some of them are essential, while others help us improve this website and your experience. You can agree to the use of unnecessary cookies by clicking on the "Accept All" button or you can decide otherwise by clicking on "Decline cookies that are not necessary". The consent includes all pre-selected cookies or cookies selected by you. You can access these settings at any time and also subsequently deselect cookies at any time (in the privacy policy and in the footer of our website) Essential Statistics Accept all Save settings Decline cookies that are not necessary Individual Privacy Settings Cookie Details Privacy Policy Imprint